D. G. McLeod

473 total citations
12 papers, 383 citations indexed

About

D. G. McLeod is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, D. G. McLeod has authored 12 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 3 papers in Molecular Biology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in D. G. McLeod's work include Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). D. G. McLeod is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). D. G. McLeod collaborates with scholars based in United States, Denmark and United Kingdom. D. G. McLeod's co-authors include Judd W. Moul, Zhengyun Zou, Vasantha Srikantan, Saurabh Kumar Srivastava, Keith D. Carter, Naga Shanmugam, Meena Augustus, Sesterhenn Ia, Michael Benson and Richard Benson and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Prostate Cancer and Prostatic Diseases.

In The Last Decade

D. G. McLeod

12 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. G. McLeod United States	8	201	130	65	62	57	12	383
Dorothée Ruffieux-Daidié Switzerland	8	86 0.4×	316 2.4×	38 0.6×	16 0.3×	116 2.0×	8	370
Aleksandra Babicheva United States	13	299 1.5×	216 1.7×	24 0.4×	76 1.2×	7 0.1×	17	487
Philippa Rabbitt Australia	12	66 0.3×	215 1.7×	123 1.9×	158 2.5×	171 3.0×	17	568
Beata Rutz Germany	14	148 0.7×	245 1.9×	33 0.5×	21 0.3×	169 3.0×	33	553
Linjie Yang China	11	30 0.1×	166 1.3×	39 0.6×	67 1.1×	43 0.8×	33	307
Saskia Wedel Germany	9	38 0.2×	112 0.9×	55 0.8×	28 0.5×	12 0.2×	21	241
Steven G. Wolfe United States	6	60 0.3×	94 0.7×	71 1.1×	15 0.2×	39 0.7×	7	321
Yasuko Matsuoka Japan	9	61 0.3×	191 1.5×	49 0.8×	17 0.3×	23 0.4×	14	387
Britt Elmedal Laursen Denmark	12	96 0.5×	115 0.9×	74 1.1×	60 1.0×	19 0.3×	28	343
Binbin Yin China	10	72 0.4×	165 1.3×	50 0.8×	79 1.3×	25 0.4×	19	337

Countries citing papers authored by D. G. McLeod

Since Specialization

Citations

This map shows the geographic impact of D. G. McLeod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. G. McLeod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. G. McLeod more than expected).

Fields of papers citing papers by D. G. McLeod

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. G. McLeod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. G. McLeod. The network helps show where D. G. McLeod may publish in the future.

Co-authorship network of co-authors of D. G. McLeod

This figure shows the co-authorship network connecting the top 25 collaborators of D. G. McLeod. A scholar is included among the top collaborators of D. G. McLeod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. G. McLeod. D. G. McLeod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

McLeod, D. G., et al.. (2011). Sipuleucel-T in African Americans: A subgroup analysis of three phase III sipuleucel-T trials in advanced prostate cancer.. Journal of Clinical Oncology. 29(15_suppl). e15148–e15148. 8 indexed citations

Gates, Jeremy D., Linda C. Benavides, Mark G. Carmichael, et al.. (2008). Long-term follow-up assessment of a HER-2/neu peptide (E75) vaccine for the prevention of recurrence in high-risk prostate cancer patients. Journal of Clinical Oncology. 26(15_suppl). 3067–3067. 1 indexed citations

Furusato, Bungo, Syed Shaheduzzaman, György Petrovics, et al.. (2007). Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens. Prostate Cancer and Prostatic Diseases. 11(2). 194–197. 25 indexed citations

Tsai, Harrison, et al.. (2006). Cancer-specific survival following radical prostatectomy or radiation therapy and short course hormonal therapy in men with localized, unfavorable-risk prostate cancer. Journal of Clinical Oncology. 24(18_suppl). 4572–4572. 1 indexed citations

See, W. A., et al.. (2006). Effect of bicalutamide 150 mg on PSA progression in M0 prostate cancer: Results from the Early Prostate Cancer program. Journal of Clinical Oncology. 24(18_suppl). 4624–4624. 1 indexed citations

Iversen, Peter, et al.. (2006). The influence of nodal status on progression outcomes in patients with prostate cancer: Data from the Early Prostate Cancer program at 7.4 years. Journal of Clinical Oncology. 24(18_suppl). 4628–4628. 3 indexed citations

Elliot, Sharon J., et al.. (2003). Pentosan polysulfate decreases prostate smooth muscle proliferation and extracellular matrix turnover. Prostate Cancer and Prostatic Diseases. 6(2). 138–142. 7 indexed citations

Paquette, Edmond L., Roger R. Connelly, Wei Zhang, et al.. (2001). Improvements in pathologic staging for African-American men undergoing radical retropubic prostatectomy during the prostate specific antigen era. Cancer. 92(10). 2673–2679. 25 indexed citations

Shanmugam, Naga, Sesterhenn Ia, Zhengyun Zou, et al.. (2000). PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer.. PubMed. 60(23). 6568–72. 166 indexed citations

10.

Eisenberger, Mario, Emily Crawford, Brent A. Blumenstein, et al.. (1994). Prognostic factors in stage D2 prostate cancer; important implications for future trials: results of a cooperative intergroup study (INT.0036). The National Cancer Institute Intergroup Study #0036.. PubMed. 21(5). 613–9. 74 indexed citations

11.

McLeod, D. G.. (1993). Antiandrogenic drugs. Cancer. 71(S3). 1046–1049. 59 indexed citations

12.

Dawson, Nancy A., George Wilding, D. G. McLeod, et al.. (1992). A pilot trial of chemohormonal therapy for metastatic prostate carcinoma. Cancer. 69(1). 213–218. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact